Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probucol plus telmisartan for type 2 diabetic nephropathy
ChiCTR-TRC-11001177Phase 4Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of probucol and telmisartan in diabetic glomerulosclerosis (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoints: 24-hour urine protein quantification and Urine albumin-to-creatinine ratio. Started Jun 2009; status: completed.
02
Drugs
probucoltelmisartan
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on ChiCTR-TRC-11001177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001177.